PMFA
MED icon

Plante Moran Financial Advisors’s Medifast MED Stock Holding History

Plante Moran Financial Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-16
Closed – – 968
2015
Q4 		$0 Buy
+16
New +$477 ﹤0.01% 973

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Plante Moran Financial Advisors's MED Position: Q1 2016 in Review

Plante Moran Financial Advisors sold out of Medifast (MED) in Q1 2016, closing a stake of 16 shares.

Plante Moran Financial Advisors first reported a position in MED in Q4 2015 and held it in 1 quarter. The position peaked at $0 in Q4 2015. 133 funds tracked by Wall St. Rank hold MED as of Q1 2016.

  • Plante Moran Financial Advisors reported no remaining Medifast position as of Q1 2016 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 16 Medifast shares in Q1 2016.
  • Plante Moran Financial Advisors first reported a position in Medifast in Q4 2015 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Medifast position peaked at $0 in Q4 2015.
  • 133 funds tracked by Wall St. Rank held Medifast as of Q1 2016.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.